Navigation Links
Four Myths About Melanoma
Date:10/30/2013

BOSTON, Oct. 30, 2013 /PRNewswire/ -- When it comes to melanoma and other skin cancers, misconceptions abound. It is important to understand what will help prevent them and what might actually increase a person's risk. Here are four common myths related to melanoma and other skin cancers.

MYTH: Dark skin doesn't burn so those with it won't get skin cancer.

FACT: All skin types and ethnic groups can develop skin cancer. While it is true that Caucasians have a greater risk of skin-related cancer, everyone should protect their skin against UV rays. Although fair-skinned people can fairly easily see stage 1 melanoma and other cancers, darker skin makes catching it in the early stages more unlikely, and darker-skinned individuals tend to develop a more lethal type of melanoma that develops on the soles of the feet, between the toes, and on the palms of the hands. Additionally, Hispanics and African-Americans who have developed skin cancer have a noticeably higher mortality rate, often due to having it diagnosed in later stages.

MYTH: Putting on sunscreen as soon as one gets to the beach will protect against skin cancer.

FACT: Sunscreen takes about 15-30 minutes to really get absorbed by skin. Although it will still make a difference, a person won't have total protection until it has been absorbed. Additionally, applying sunscreen every two to four hours- and more frequently if you're in the water- while in the sun is highly recommended. Also, people should make sure to choose a broad-spectrum sunscreen with an SPF of 30, especially those with fair skin.

MYTH: Unexposed skin can't get melanoma and doesn't need to be checked.

FACT: Unfortunately, melanoma can be developed on the soles of feet, beneath toenails and fingernails, in some organs and even in the eyes. Whether skin is exposed or not, it is still at risk of melanoma and should be checked during a cancer screening.

MYTH: Only people who tan regularly get skin cancer.

FACT: Anyone can get melanoma or other skin-related cancers. If there are any signs that a mole is changing shape or color, or a patch of skin has become harder or discolored, a doctor should be consulted. If cancer is detected, it is important to keep abreast of the latest advances in detection and treatment.

For example, Caliber I.D., with facilities in Rochester and Boston, is currently the only company in the world to offer an FDA-cleared in vivo confocal microscope designed specifically for imaging skin and other tissue. Caliber I.D.'s Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

More than 15 years of engineering and development at US-based Caliber I.D. combined with feedback from independent researchers in the United States, Europe, and Australia, has resulted in the VivaScope, a robust suite of imaging products. The VivaScope® suite offers breakthrough technology that represents a new era in medical imaging. Physicians now have a cellular-level view of the patient's skin at the bedside, allowing for immediate tissue characterization and treatment. For those cases that require additional support from other specialists, Caliber I.D.'s telepathology system allows near real-time collaboration with remote specialists.

For more information, please visit www.caliberid.com, which paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE Caliber I.D.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens
2. New Study Debunks Wastage Myths of Prescriptions Filled in Medicare Part D
3. Leading Cardiologist Dispels the Myths about Dietary Supplement Niacin
4. New White Paper, "Five Biggest Myths about Medical Products Outsourcing," Finds OEMs Concerns are Often Unfounded
5. FDA 483s and Warning Letters list inadequate CAPA practices! What are Medical Device Manufacturers doing about it?
6. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
7. Many Women Not Warned About Mesh Implant Risks
8. Distinguished Health Group Speaks about Swissray Benefits
9. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
10. Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
11. The World Customs Organization (WCO) and the Institute of Research Against Counterfeit Medicines (IRACM) issue a new warning about the health and safety of African populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):